AI assistant
Excell Industries Ltd. — Earnings Release 2022
May 27, 2022
63426_rns_2022-05-27_2cfa46be-82e3-427c-ae4c-da83f464fb9a.pdf
Earnings Release
Open in viewerOpens in your device viewer


27th May, 2022
BSE Ltd. Listing Department, Pheeroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400 001
National Stock Exchange of India Ltd. Listing Department, Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai-400 051
Sub: Outcome of Board Meeting.
Ref: BSE Scrip Code: 500650; NSE Scrip Code: EXCELINDUS
Dear Sir,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that at the meeting of the Board of Directors of the Company held today, the Board has approved audited financial results (Standalone and Consolidated) of the Company for the year ended 31st March, 2022 which were earlier approved and recommended by the Audit Committee of the Company at its meeting held today.
Pursuant to Regulation 33(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please f nd attached herewith the following:
-
- Auditors' Report on the audited financial results (Standalone and Consolidated) for the year ended 31st March, 2022
-
- Audited (Standalone and Consolidated) Financial Results for the quarter and year ended 31st March, 2022.
-
- Segment-wise information, Cash Flow Statement and Statement of Assets and Liabilities
In compliance with the provisions of the Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board declares that the above Auditors' Report is with unmodified opinion with respect to Financial Results (Standalone & Consolidated) of the Company for the year ended 31st March, 2022.
Further, the Board has recommended a dividend of Rs. 22.50/- (450%) per equity share of the face value of Rs. 5 /- each for the FY 2021-22, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company.
Excel Industries Limited 184-87, S. V. Road, Jogeshwari (West), Mumbai - 400 102, Maharashtra, India. CIN: L24200MH1960PLC011807
E: [email protected] T: 91- 22 - 6646 4200 F: +91-22-2678 3657 W: http://www.excelind.co.in


The dividend will be paid within 30 days of its declaration by the shareholders at the AGM. The date of AGM will be informed in due course.
The Board meeting commenced at 02:00 p.m. and concluded at 06:15 p.m.
Kindly take the information on your record.
Thanking you,
Yours faithfully, For Excel Industries Limited
SK Singhvi Company Secretary Encl: As above
Chemicals Business | Environment & Biotech Division Polymer Inputs | Pharmaceutical Intermediates | Veterinary API's Excel Industries Limited 184-87, S. V. Road, Jogeshwari (West), Mumbai - 400 102, Maharashtra, India. CIN: L24200MH1960PLC011807
E: [email protected] T: 91-22 - 6646 4200 F: +91-22-2678 3657 W: http://www.excelind.co.in
INDEPENDENT AUDITOR'S REPORT
To the Board of Directors of Excel Industries Limited
Report on the Audit of Standalone Financial Results
Opinion
-
- We have audited the statement of standalone financial results for the year ended March 31, 2022 of Excel Industries Limited (hereinafter referred to as the 'Company") and the statement of standalone assets and liabilities and the statement of standalone cash flows as at and for the year ended on that date including notes thereon (together referred to as the 'standalone financial results'), attached herewith, being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations').
- In our opinion and to the best of our information and according to the explanations given $\overline{2}$ . to us, the aforesaid standalone financial results:
- are presented in accordance with the requirements of Regulation 33 of the Listing i. Regulations in this regard; and
- give a true and fair view in conformity with the recognition and measurement ii. principles laid down in the applicable accounting standards prescribed under Section 133 of the Companies Act, 2013 (the "Act") and other accounting principles generally accepted in India, of net profit and other comprehensive income and other financial information of the Company for the year ended March 31, 2022 and the statement of standalone assets and liabilities and the statement of standalone cash flows as at and for the year ended on that date.
Basis for Opinion
We conducted our audit in accordance with the Standards on Auditing (SAs) specified under Section 143(10) of the Act and other applicable authoritative pronouncements issued by the Institute of Chartered Accountants of India. Our responsibilities under those Standards are further described in the 'Auditor's Responsibilities for the Audit of the Standalone Financial Results' section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our opinion.

Price Waterhouse Chartered Accountants LLP, Nesco IT Building III, 8th Floor, Nesco IT Park. Nesco Complex. Gate No. 3 Western Express Highway, Goregaon East, Mumbai - 400 063 T: $+91(22)61198000$ , F: $+91(22)61198799$
Registered office and Head office: Sucheta Bhawan, 11A Vishnu Digambar Marg, New Delhi 110 002
Price Waterhouse (a Partnership Firm) converted into Price Waterhouse Charlered Accountants LLP (a Limited Liability Partnership with LLP identity no: LLPIN AAC-5001) with effect from July 25, 2014. Post its conversion to Price Waterhouse Chartered Accountants LLP, its ICAI registration number is 012754N/N500016 (ICAI registration number before conversion was 012754N)
INDEPENDENT AUDITOR'S REPORT To the Board of Directors of Excel Industries Limited Report on the Standalone Financial Results Page 2 of 4
Board of Directors' Responsibilities for the Standalone Financial Results
-
- These Standalone financial results have been prepared on the basis of the standalone annual financial statements. The Company's Board of Directors are responsible for the preparation and presentation of these standalone financial results that give a true and fair view of the net profit and other comprehensive income and other financial information of the Company and the statement of standalone assets and liabilities and the statement of standalone cash flows in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Board of Directors of the Company are responsible for maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring accuracy and completeness of the accounting records, relevant to the preparation and presentation of the standalone financial statements that give a true and fair view and are free from material misstatement. whether due to fraud or error, which have been used for the purpose of preparation of the standalone financial results by the Directors of the Company. as aforesaid.
-
- In preparing the standalone financial results, the Board of Directors of the Company are responsible for assessing the ability of the Company to continue as a going concern. disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.
-
- The Board of Directors of the Company are responsible for overseeing the financial reporting process of the Company.
Auditor's Responsibilities for the Audit of the Standalone Financial Results
- Our objectives are to obtain reasonable assurance about whether the standalone financial results as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone financial results.

INDEPENDENT AUDITOR'S REPORT To the Board of Directors of Excel Industries Limited Report on the Standalone Financial Results Page 3 of 4
-
- As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
- Identify and assess the risks of material misstatement of the standalone financial results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3) (i) of the Act, we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls. (Refer paragraph 11 below).
- Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board of Directors.
- Conclude on the appropriateness of the Board of Directors use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Company to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the standalone financial results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.
- Evaluate the overall presentation, structure and content of the standalone financial results, including the disclosures, and whether the standalone financial results represent the underlying transactions and events in a manner that achieves fair presentation.
-
- We communicate with those charged with governance of the Company regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

INDEPENDENT AUDITOR'S REPORT To the Board of Directors of Excel Industries Limited Report on the Standalone Financial Results Page 4 of 4
Other Matters
-
- The Standalone Financial Results include the results for the quarter ended March 31, 2022 being the balancing figures between the audited figures in respect of the full financial year and the published unaudited year to date figures up to the third quarter of the current financial year, which are neither subject to limited review nor audited by us.
-
- The standalone annual financial results dealt with by this report has been prepared for the express purpose of filing with Stock exchanges on which the Company's shares are listed. These results are based on and should be read with the audited standalone financial statements of the Company for the year ended March 31, 2022 on which we issued an unmodified audit opinion vide our report dated May 27, 2022.
For Price Waterhouse Chartered Accountants LLP Firm Registration Number: 012754N/N500016
Nehal Upadhayay Partner Membership Number: 115872 UDIN: 22115872AJSGDY6665
Place: Mumbai Date: May 27, 2022


STATEMENT OF STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2022
| Quarter Ended | Year Ended | (KS. IN LAKNS | ||||
|---|---|---|---|---|---|---|
| Sr. No. |
Particulars | March 31, 2022 |
December 31, 2021 |
March 31, 2021 |
March 31, 2022 |
March 31, 2021 |
| (Unaudited) (Refer Note 3) |
(Unaudited) | (Unaudited) (Refer Note 3) |
(Audited) | (Audited) | ||
| 1 | Income | |||||
| (a) Revenue from operations | 36,466.54 | 35.052.39 | 21,867.81 | 117,801.98 | 74,946.60 | |
| (b) Other incorne | 112.51 | 840.17 | 96.14 | 1,421.12 | 825.78 | |
| Total Income (1) | 36,579.05 | 35,892.56 | 21,963.95 | 119,223.10 | 75,772.38 | |
| $\overline{2}$ | Expenses | |||||
| (a) Cost of materials consumed | 19,787.88 | 16,410.48 | 10,724.25 | 62,137.68 | 35,904.44 | |
| (b) Purchases of stock-in-trade | 148,75 | 114.58 | 104.87 | 452.56 | 223.21 | |
| (c) Changes in inventories of finished goods, stock-in-trade and work-in-progress | 260.28 | (1, 139.62) | (218.03) | (1.899.95) | 793.96 | |
| (d) Employee benefits expenses (e) Finance costs |
2,880.59 | 2,952.51 | 2,377.97 | 10,619.65 | 8,938.07 | |
| (f) Depreciation and amortisation expense | 42.47 773.65 |
43.01 820.87 |
42.64 695.18 |
192.38 3,065.50 |
217.57 2,715.32 |
|
| (g) Other expenses | 6,711.33 | 6,442.40 | 5,013.56 | 23,445.25 | 17,009.53 | |
| Total Expenses (2) | 30,604.95 | 25,644.23 | 18,740.44 | 98,013.07 | 65,802.10 | |
| 3 | Profit before exceptional items and tax (1-2) | 5,974.10 | 10,248.33 | 3,223.51 | 21,210.03 | 9,970.28 |
| 4 | Exceptional ilems | |||||
| 5 | Profit before tax (3-4) | 5,974.10 | 10,248.33 | 3,223.51 | 21,210.03 | 9,970.28 |
| 6 | Tax expense | |||||
| - Current tax (Refer Note 5) | 1,473.98 | 2,431.50 | 735.20 | 5,072.35 | 2,162.07 | |
| - Deferred tax (Refer Note 5) | 28.63 | 1.13 | 497.24 | 121.76 | 789.26 | |
| Profit for the period (after tax) (5-6) Other Comprehensive Income / (Loss) |
4,471.49 | 7,815.70 | 1,991.07 | 16,015.92 | 7,018.95 | |
| A (i) Items that will not be reclassified to profit or loss (Refer Note 4) | 1,177.76 | (600, 46) | 1.413.64 | 8,539.27 | 5,228.58 | |
| (ii) Income tax relating to the items that will not be reclassified to profit or loss | (242.28) | 68.96 | (244.94) | (1, 453.70) | (777.05) | |
| B (i) Items that will be reclassified to profit or loss | ٠ | ٠ | ||||
| (ii) Income tax relating to the items that will be reclassified to profit or loss | ×, | |||||
| 9 | Total Comprehensive Income / (Loss) for the period (7+8) | 5,406.97 | 7,284.20 | 3,159,77 | 23,101.49 | 11,470.48 |
| 10 11 |
Pald up Equity Share Capital (face value of Rs. 5/- per Equity Share) Eamings per share (EPS) - in Rs. |
628.53 | 628.53 | 628.53 | 628.53 | 628.53 |
| Earning Per Shares of Rs 5/- each (not annualised) | ||||||
| Basic | 35.57 | 62.17 | 15.84 | 127.41 | 55.84 | |
| Diluted | 35.57 | 62.17 | 15.84 | 127.41 | 55.84 | |



Chemicals Business | Environment & Biotech Division
Polymer Inputs | Pharmaceutical Intermediates | Veterinary API's
Excel Industries Limited
184-87, S. V. Road, Jogeshwari (West),
Mumbai - 400 102, Maharashtra, India.
CIN : L24200MH1960PLC011807
E: [email protected]
T: 91- 22 - 6646 4200
F : +91-22-2678 3657
W: http://www.excelind.co.in


NOTES TO STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2022:
- The standalone financial results for the quarter and year ended March 31, 2022 were reviewed by the Audit Committee and approved by the Board of Directors of Excel Industries Limited ('the Company') at their meetings held on May 27, 2022.
- 2 The Board of Directors have recommended dividend of 1t 5'. a> -f. amounting to Rs. � :l. is/ per equity share of Rs. 5,00 each (Previous year : Rs. 11.25 per equity share) for the year ended March 31, 2022 subject to approval of shareholders.
- 3 The figures for the quarter ended March 31, 2022 and March 31; 2021 are arrived at as difference between audited figures in respect of the full financial year ended March 31, 2022 and March 31, 2021, and unaudited figures up to nine months ended December 31, 2021 and December 31, 2020 respectively, which were reviP,wed earlier �nd not subjected to audit.
- 4 Other Comprehensive Income include increase in Fair Value of Investments in equity Instruments amounting to Rs. 1,215,15 lakhs and Rs. 8,538,62 lakhs for the quarter and year ended March 31, 2022.
- 5 During the previous year, current tax expenses for the quarter and year ended March 31, 2021 Included Rs, 65.82 lakhs being the tax impact of goodwill taken out of purview of tax depreciation with effect from April 1, 2020 by Finance Bill enacted in March 2021. Further, deferred tax charge for the quarter and year ended March 31, 2021 Included Rs, 282.33 lakhs being the deferred tax liabilities recognised by the Company on difference between book based and tax base of goodwill consequent upon enactment of above provision,
- 6 The Ministry of Corporate Affairs through a notification dated March 24, 2021, amended Schedule Ill of the Companies Act, 2013, applicable for financial periods commencing from April 1, 2021. Pursuant to such amendments, security deposits amounting to Rs, 711.87 lakhs as at March 31, 2021 have been reclassified from 'Loans' to 'Other financial assets' and current maturities of long term debts amounting to Rs. 1.57 lakhs as at March 31, 2021 have been reclassified from 'Other financial liabilities' to 'Current borrowinAs'. These reclassifications were also considered in the Statement of Standalone Cash Flows for the year ended March 31, 2021,


Chemicals Business I Environment & Biotech Division Polymer Inputs I Pharmaceutical Intermediates I Veterinary APl's
Excel Industries Limited 184-87, S. V. Road, Jogeshwari (West), Mumbai - 400 102, Maharashtra, India. GIN: L24200MH1960PLC011807
E: [email protected] T 91- 22 - 6646 4200 F : +91-22-2678 3657 W: http://www.excelind.co.in


7 Segment Information:
| (Rs. In Lakhs) | |||||
|---|---|---|---|---|---|
| For the Quarter ended | For the Year ended | ||||
| Particulars | March 31, 2022 | December 31, 2021 | March 31, 2021 | March 31, 2022 | March 31, 2021 |
| (Unaudited) (Refer Note 3) |
(Unaudited) | (Unaudited) (Refer Note 3) |
(Audited) | (Audited) | |
| Segment Revenue (Revenue from | |||||
| operations) | |||||
| Chemicals | 35,944.65 | 34,138.52 | 21.351.86 | 115,253.96 | 72,993.84 |
| Environment and Blotech | 521.89 | 913.87 | 515.95 | 2,548.02 | 1,952.76 |
| Total Segment Revenue | 36,466.54 | 35,052.39 | 21,867.81 | 117,801.98 | 74,946.60 |
| Less: Inter segment revenue | |||||
| Net Segment Revenue | 36,466.54 | 35,052.39 | 21,867.81 | 117,801.98 | 74,946.60 |
| Segment Results (Profit before tax and interest) |
|||||
| Chemicals | 7,456.28 | 10,818.46 | 4,267.80 | 24,827.19 | 13,080.08 |
| Environment and Blotech | (56.38) | 212.39 | (35.08) | 256.88 | 8.25 |
| Total Segment Results | 7,399,90 | 11,030.85 | 4,232.72 | 25,084.07 | 13,088.33 |
| Less: Finance cost Other unallocable expenditure |
42.47 | 43.01 | 42.64 | 192.38 | 217.57 |
| (net of unallocable income) | 1,383.33 | 739.51 | 966.57 | 3,681.66 | 2,900.48 |
| Profit before tax | 5,974.10 | 10,248.33 | 3,223.51 | 21,210.03 | 9,970.28 |
| Segment Assets | |||||
| Chemicals | 78.735.62 | 72,380.38 | 61,441.26 | 78,735.62 | 61,441.26 |
| Environment and Biotech | 1,986.31 | 1,885.55 | 1,375.66 | 1,986.31 | 1,375.66 |
| Unallocated | 42,455.81 | 38,815,81 | 32,523.57 | 42,455.81 | 32,523.57 |
| Total Segment Assets | 123, 177. 74 | 113,081.74 | 95,340.49 | 123,177.74 | 95,340.49 |
| Segment Liabilities | |||||
| Chemicals | 18,556.07 | 14,431.17 | 12,824.58 | 18,556.07 | 12,824.58 |
| Environment and Biotech | 467.60 | 348.74 | 235.16 | 467.60 | 235.16 |
| Unallocated | 10,881.39 | 10,436.22 | 10,695.35 | 10,881.39 | 10,695.35 |
| Total Segment Liabilities | 29,905,06 | 25,216.13 | 23,755.09 | 29,905.06 | 23,755.09 |
Place: Mumbal Date: May 27, 2022

For EXCEL MOUSTRIES LIMITED
ASHWIN C. SHROFF
EXECUTIVE CHAIRMAN
DIN: 00019952

Chemicals Business | Environment & Biotech Division
Polymer Inputs | Pharmaceutical Intermediates | Veterinary API's
Excel Industries Limited Licer muustries Limited
184-87, S. V. Road, Jogeshwari (West),
Mumbai - 400 102, Maharashtra, India.
CIN : L24200MH1960PLC011807 E: [email protected]
T: 91- 22 - 6646 4200
F : +91-22-2678 3657
W: http://www.excelind.co.in


$n - 1 - 1 - 1$
STATEMENT OF STANDALONE ASSETS AND LIABILITIES
| Sr. No. | Particulars | As at | ||
|---|---|---|---|---|
| March 31, 2022 (Audited) |
March 31, 2021 (Audited) |
|||
| A | Assets | |||
| 1 | Non-current assets Property, plant and equipment Right of use assets Capital work In progress Investment properties Intanglble assets Financial assets |
38,463.73 2,222.07 2,120.25 83.40 1,918.99 |
34,593.80 2,289.50 1,685.19 85.32 1,918.46 |
|
| (I) Investments in subsidiaries and joint venture (ii) Other Investments (Refer Note 4) (iii) Loans (Refer Note 6) (iv) Other financial assets (Refer Note 6) Current tax assets (net) Other non-current assets Total non-current assets |
421.47 28,165.84 4.37 630.49 1,784.99 119.15 75,934.75 |
421.47 19,627.22 5.14 621.65 1,803.98 218.32 63,270.05 |
||
| 2 | Current assets | |||
| Inventories Financial assets |
16,522.58 | 6,897.11 | ||
| (i) Investments (ii) Trade recelvables |
905.15 19,918.46 |
869.67 17,264.02 |
||
| (iii) Cash and cash equivalents | 2,840.11 | 4.210.40 | ||
| (iv) Bank balances other than (iii) above | 3,749.83 | 954.97 | ||
| (v) Loans (Refer Note 6) | 32.44 | 34.51 | ||
| (vi) Other financial assets (Refer Note 6) | 239,80 | 177.56 | ||
| Other Current assets Total current assets |
3,034.62 | 1,662.20 32,070.44 |
||
| 47,242.99 | ||||
| Total Assets | 123, 177.74 | 95,340.49 | ||
| В | Equity and Liabilities | |||
| 1 | Equity Equity share capital |
628.53 | 628.53 | |
| Other equity | 92,644.15 | 70,956.87 | ||
| Total equity | 93,272.68 | 71,585.40 | ||
| $\overline{2}$ | Liabilities Non-current liabilities Financial liabilities (i) Borrowings |
0.55 | ||
| (ii) Lease liabilities | 178.33 | 217.33 | ||
| Employee benefit obligations | 1,421.43 | 1,296.45 | ||
| Deferred tax liabilities (net) Total Non-current liabilities |
8,079.19 9,678.95 |
6,503.73 8,018.06 |
||
| 3 | Current liabilities | |||
| Financial llabilities (i) Borrowings (Refer Note 6) |
523.53 | 608.69 | ||
| (ii) Trade payable | ||||
| (a) total outstanding dues of micro and small enterprises | 1,432.38 | 1,160.87 | ||
| (b) total outstanding dues other than (ii) (a) above (iii) Lease liabilitles |
16,609.97 39.18 |
11,137.58 33.73 |
||
| (Iv) Other financial liabilities (Refer Note 6) | 456.62 | 1,550.53 | ||
| Employee benefit obligations | 510.16 | 735.93 | ||
| Current tax llabilities (net) | 294.72 | 178.14 | ||
| Other current liabilities | 359.55 | 331.56 | ||
| Total current liabilities | 20,226.11 | 15,737.03 | ||
| Total Equity and Llabilities | 123, 177.74 | 95,340.49 |
MUMBAI
400102
Ą
Chemicals Business | Environment & Biotech Division
Polymer Inputs | Pharmaceutical Intermediates | Veterinary API's
Mumbal
Excel Industries Limited Excer muusures Emmeu
184-87, S. V. Road, Jogeshwari (West),
Mumbai - 400 102, Maharashtra, India.
CIN : L24200MH1960PLC011807 E: [email protected]
T: 91- 22 - 6646 4200
F: +91-22-2678 3657 W: http://www.excelind.co.in


STATEMENT OF STANDALONE CASH FLOWS
| (Rs. in Lakhs) Year Ehded |
|||||
|---|---|---|---|---|---|
| March 31, | March 31, | ||||
| Particulars | 2022 | 2021 | |||
| (Audited) | (Audited) | ||||
| CASH FLOW FROM OPERATING ACTIVITIES: | |||||
| Profit before tax | 21,210.03 | 9,970.28 | |||
| Adjustments for: | |||||
| Depreciation and amortisation expenses | 3,065.50 | 2,715.32 | |||
| Finance costs | 192.38 | 217.57 | |||
| Provision for doubtful debts (net) | 26.08 | 154.64 | |||
| Provision for doubtful advance | 80.78 | 83.78 | |||
| Unrealised exchange differences (net) | 38,43 | 13.68 | |||
| Dividend Income | (1,074.88) | (372.43) | |||
| Interest income | (247.38) | (153.61) | |||
| Gain on fair valuation of investments through profit and loss | (0.53) | (1.58) | |||
| Profit on sale of investment property | (137.05) | ||||
| Net loss on sale / discard of property, plant and equipment | 30.38 | 38.58 | |||
| Operating profit before working capital changes | 23,320.79 | 12,629.18 | |||
| Adjustments for: | |||||
| (Increase) / decrease in Inventories | (9,625.47) | 874.86 | |||
| (Increase) / decrease In Trade Receivables | (2,667.37) | (2,452,39) | |||
| (Increase) / decrease in Other Bank balances | 668.62 | (820.44) | |||
| (Increase) / decrease In Loans (Current and Non current) (Refer Note 6) | 2.84 | (15.87) | |||
| (Increase) / decrease in Other Financial Assets (Current and Non current) (Refer Note 6) | (41.55) | (74.73) | |||
| (Increase) / decrease in Other Assets (Current and Non current) | (1, 439.55) | (604.13) | |||
| Increase / (decrease) In Trade Payables | 5,692.32 | 1,801.44 | |||
| Increase / (decrease) In Other Financial Liabilities (Current and Non current) | (9.53) | 11.86 | |||
| Increase / (decrease) in Employee benefit obligations (Current and Non current) Increase / (decrease) in Other Current Liabilities |
(100.14) 27.99 |
(13.78) 104.41 |
|||
| 15,828.95 | 11,340.41 | ||||
| Less: Income taxes pald (net of refunds) | 4,936.78 | 2.325.33 | |||
| NET CASH INFLOW GENERATED FROM OPERATING ACTIVITIES - [A] | 10.892.17 | 9,015.08 | |||
| CASH FLOW FROM INVESTING ACTIVITIES: | |||||
| Purchase of Tangible assets (Including capital work in progress, capital advances and Capital Vendor) | (7,370.71) | (4,769.46) | |||
| Purchase of Intangible assets | (18.73) | (2.04) | |||
| Payment towards acquisition of business | (1,000.00) | (750.00) | |||
| Proceed from sale of fixed assets | 20.20 | 16.24 | |||
| Proceed from sale of Investment property | 191.94 | ||||
| Investments in bank deposits with maturity of more than three months (net) | (3,463.57) | $\bullet$ | |||
| Interest recelved | 217.94 | 153.09 | |||
| Dividend recelved Purchase of current Investments |
1,074.88 | 372.43 | |||
| NET CASH (OUTFLOW) FROM INVESTING ACTIVITIES - [B] | (34.95) (10.574.94) |
(30.61) (4.818.41) |
|||
| CASH FLOW FROM FINANCING ACTIVITIES: | |||||
| Repayment of Borrowings | (85.71) | (1,523.16) | |||
| Principal elements of lease payments | (53.14) | (50.39) | |||
| Repayment of Fixed deposits accepted from public (including Interest) | (1.33) | (0.97) | |||
| Dividend Paid | (1,415.70) | ||||
| Interest Paid | (131.64) | (108.54) | |||
| NET CASH (OUTFLOW) FROM FINANCING ACTIVITIES - [C] | (1,687,52) | (1,683.06) | |||
| NET INCREASE / (DECREASE) IN CASH AND CASH EQUIVALENTS = [A+B+C] | (1,370.29) | 2,513.61 | |||
| Add: Cash and cash equivalents at the beginning of the year | 4.210.40 | 1,696.79 | |||
| Cash and cash equivalents at the end of the year | 2,840.11 | 4,210.40 | |||

÷,
MUMBAI 400102
E: [email protected]
T: 91- 22 - 6646 4200
F : +91-22-2678 3657 W: http://www.excelind.co.in
Chemicals Business | Environment & Biotech Division
Polymer Inputs | Pharmaceutical Intermediates | Veterinary API's
Excel Industries Limited 184-87, S. V. Road, Jogeshwari (West),
Mumbai - 400 102, Maharashtra, India. CIN : L24200MH1960PLC011807
INDEPENDENT AUDITOR'S REPORT
To the Board of Directors of Excel Industries Limited
Report on the Audit of the Consolidated Financial Results
Opinion
-
- We have audited the Statement of consolidated financial results for the vear ended March 31. 2022 of Excel Industries Limited (hereinafter referred to as the "Holding Company") and its subsidiaries (Holding Company and its subsidiaries together referred to as "the Group") and its associate companies and the statement of consolidated assets and liabilities and the statement of consolidated cash flows as at and for the year ended on that date including the notes thereon (together referred to as the 'consolidated financial results'), attached herewith. being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (the "Listing" Regulations").
- In our opinion and to the best of our information and according to the explanations given to $\overline{2}$ . us and based on the consideration of reports of the other auditors on separate audited financial statements of subsidiaries, the aforesaid consolidated financial results:
- i. include the annual financial results of the following entities:
Kamaljyot Investments Limited - Subsidiary Company Excel Bio Resources Limited - Subsidiary Company Mobitrash Recycle Ventures Private Limited - Associate Company Climacrew Private Limited - Associate Company
- ii. are presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard; and
- iii. give a true and fair view, in conformity with the recognition and measurement principles laid down in the applicable accounting standards prescribed under Section 133 of the Companies Act, 2013 (the "Act") and other accounting principles generally accepted in India, of net profit and other comprehensive income and other financial information of the Group and its associate companies for the year ended March 31, 2022 and the statement of consolidated assets and liabilities and the statement of consolidated cash flows as at and for the year ended on that date.
Basis for Opinion
- We conducted our audit in accordance with the Standards on Auditing (SAs) specified under Section $143(10)$ of the Act and other applicable authoritative pronouncements issued by the Institute of Chartered Accountants of India. Our responsibilities under those Standards are further described in the 'Auditor's Responsibilities for the Audit of the consolidated financial results' section of our report. We are independent of the Group and its associate companies in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the consolidated financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us and other auditors in terms of their reports referred to in "Other Matter" paragraph below, is sufficient and appropriate to provide a basis for our opinion.
Price Waterhouse Chartered Accountants LLP, Nesco IT Building III, 8th Floor, Nesco IT Park Nesco Complex, Gate No. 3 Western Express Highway, Goregaon East, Mumbai - 400 063 $T: +91(22) 61198000, F: +91(22) 61198799$
Registered office and Head office: Sucheta Bhawan, 11A Vishnu Digambar Marg, New Delhi 110 002
Price Waterhouse (a Partnership Firm) converted into Price Waterhouse Chartered Accountants LLP (a Limited Liability Partnership with LLP identity no: LLPIN AAC-5001 with effect from July 25, 2014. Post its conversion to Price Waterhouse Chartered Accountants LLP, its ICAI registration number is 012754N/N500016 (ICAI registration number before conversion was 012754N)
INDEPENDENT AUDITOR'S REPORT To the Board of Directors of Excel Industries Limited Report on the Consolidated Financial Results Page 2 of 5
Board of Director's Responsibilities for the Consolidated Financial Results
- These Consolidated financial results have been prepared on the basis of the consolidated annual financial statements. The Holding Company's Board of Directors are responsible for the preparation and presentation of these consolidated financial results that give a true and fair view of the net profit and other comprehensive income and other financial information of the Group including its associate companies and the statement of consolidated assets and liabilities and statement of consolidated cash flows in accordance with the recognition and measurement principles laid down in Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The respective Board of Directors of the companies included in the Group and of its associate companies are responsible for maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Group and its associate companies and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring accuracy and completeness of the accounting records, relevant to the preparation and presentation of the consolidated financial results that give a true and fair view and are free from material misstatement, whether due to fraud or error, which have been used for the purpose of preparation of the consolidated financial results by the Directors of the Holding Company, as aforesaid.
-
- In preparing the consolidated financial results, the respective Board of Directors of the companies included in the Group and of its associate companies are responsible for assessing the ability of the Group and of its associate companies to continue as a going concern, disclosing, as applicable matters related to going concern and using the going concern basis of accounting unless the respective Board Directors either intends to liquidate the Group and its associate companies or to cease operations, or has no realistic alternative but to do so.
-
- The respective Board of Directors of the companies included in the Group and of its associate companies are responsible for overseeing the financial reporting process of the Group and of its associate companies.
Auditor's Responsibilities for the Audit of the Consolidated Financial Results
- Our objectives are to obtain reasonable assurance about whether the consolidated financial results as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial results.

INDEPENDENT AUDITOR'S REPORT
To the Board of Directors of Excel Industries Limited Report on the Consolidated Financial Results Page 3 of 5
-
- As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
- Identify and assess the risks of material misstatement of the consolidated financial results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143 (3)(i) of the Act, we are also responsible for expressing our opinion on adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls. (Refer para 15 below)
- Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board of Directors.
- Conclude on the appropriateness of the Board of Director's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Group and its associate companies to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the consolidated financial results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group and its associate companies to cease to continue as going concern.
- Evaluate the overall presentation, structure and content of the consolidated financial results, including the disclosures, and whether the consolidated financial results represent the underlying transactions and events in a manner that achieves fair presentation.
- Obtain sufficient appropriate audit evidence regarding the financial statements of the entities within the Group and its associate companies to express an opinion on the consolidated financial results. We are responsible for the direction, supervision and performance of the audit of financial information of such entities included in the consolidated financial results of which we are the independent auditors. For the other entities included in the consolidated financial results, which have been audited by other auditors, such other auditors remain responsible for the direction, supervision and performance of the audits carried out by them. We remain solely responsible for our audit opinion.

INDEPENDENT AUDITOR'S REPORT To the Board of Directors of Excel Industries Limited Report on the Consolidated Financial Results Page 4 of 5
-
- We communicate with those charged with governance of the Holding Company of which we are the independent auditors regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.
-
- We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the Listing Regulations, as amended, to the extent applicable.
Other Matters
-
- We did not audit the financial statement of two subsidiaries included in the consolidated financial results, whose financial statements reflect total assets of Rs. 25,908.68 lakhs and net assets of Rs. 22,084.10 lakhs as at March 31, 2022, total revenues of Rs. Nil, total net profit after tax of Rs. 144.33 lakhs and total comprehensive income of Rs. 8.133.58 lakhs for the year ended March 31, 2022 and cash inflows of Rs. 166,20 lakhs for the year ended March 31, 2022, as considered in the consolidated financial results. These financial statements have been audited by other auditors whose reports have been furnished to us by the Management and our opinion on the consolidated financial results, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries is based solely on the reports of the other auditors and the procedures performed by us as stated in paragraph 10 above.
-
- The consolidated financial results includes the Group's share of net profit / (loss) after tax of Rs. Nil and total comprehensive income of Rs. Nil for the year ended March 31, 2022, as considered in the consolidated financial results, in respect of two associates whose financial statements have not been audited by us. These financial statements are unaudited and have been furnished to us by the Management and our opinion on the consolidated financial results, in so far as it relates to the amounts and disclosures included in respect of these associates is based solely on such unaudited financial statements. In our opinion and according to the information and explanations given to us by the Management, these financial statements are not material to the Group.
-
- Our opinion on the consolidated financial results is not modified in respect of the above matters with respect to our reliance on the work done and the reports of the other auditors and the financial results certified by the Board of Directors.
-
- The consolidated financial results include the results for the quarter ended March 31, 2022 being the balancing figures between the audited figures in respect of the full financial year and the published unaudited year to date figures upto the third quarter of the current financial year, which are neither subject to limited review nor audited by us.

INDEPENDENT AUDITOR'S REPORT To the Board of Directors of Excel Industries Limited Report on the Consolidated Financial Results Page 5 of 5
- The consolidated annual financial results dealt with by this report have been prepared for the express purpose of filing with stock exchanges on which the Company's shares are listed. These results are based on and should be read with the audited consolidated financial statements of the group and its associate companies, for the year ended March 31, 2022 on which we have issued an unmodified audit opinion vide our report dated May 27, 2022.
For Price Waterhouse Chartered Accountants LLP Firm Registration Number: 012754N/N500016
blular
Nehal Upadhayay Partner Membership Number: 115872 UDIN: 22115872AJSGJX7647
Place: Mumbai Date: May 27, 2022


| (Rs. in Lakhs) | ||||||
|---|---|---|---|---|---|---|
| Quarter Ended | Year Ended | |||||
| Sr. No. | Particulars | March 31. 2022 |
December 31, 2021 |
March 31, 2021 |
March 31, 2022 |
March 31, 2021 |
| (Unaudited) (Rafer Note 3) |
(Unaudited) | (Unaudited) (Refer Note 3) |
(Audited) | (Audited) | ||
| 1 | Income | |||||
| (a) Revenue from operations | 36,466.54 | 35,052.39 | 21,867.81 | 117,801.98 | 74,946.60 | |
| (b) Other income | 122.26 | 812.62 | 111.61 | 1.563.63 | 941.32 | |
| Total Income (1) | 36,588.80 | 35,865.01 | 21,979.42 | 119,365.61 | 75,887.92 | |
| $\overline{2}$ | Expenses | 19,787.88 | 16,410,48 | 10,724.25 | 62,137.68 | 35,904.44 |
| (a) Cost of materials consumed (b) Purchases of stock-in-trade |
148.75 | 114.58 | 104.87 | 452.56 | 223.21 | |
| (c) Changes in inventories of finished goods, stock- in-trade and work-in-progress | 260.28 | (1, 139.62) | (218.03) | (1,899.95) | 793.96 | |
| (d) Employee benefits expenses | 2,880.59 | 2,952.51 | 2,377.97 | 10,619.65 | 8,938.07 | |
| (e) Finance costs | 43.88 | 43.01 | 42.95 | 193,79 | 217.88 | |
| (f) Depreciation and amortisation expense | 773.65 | 820.87 | 695.18 | 3,065.50 | 2,715.32 | |
| (g) Other expenses | 6,712.69 | 6,443.92 | 5,013.38 | 23,451.00 | 17,014.07 | |
| Total Expenses (2) | 30,607.72 | 25,645.75 | 18,740.57 | 98,020.23 | 65,806,95 | |
| Profit before exceptional items, share of net profits of investments accounted for using | ||||||
| 3 | equity method and tax (1-2) | 5,981.08 | 10,219.26 | 3,238.85 | 21,345.38 | 10,080.97 |
| 4 | Share of net profit / (loss) of associate accounted for using equity method | |||||
| 5 | Profit before exceptional items and tax (3-4) | 5,981.08 | 10,219.26 | 3,238.85 | 21,345.38 | 10,080.97 |
| 6 | Exceptional items | |||||
| $\overline{7}$ | Profit before tax (5-6) | 5,981.08 | 10,219.26 | 3,238.85 | 21,345.38 | 10,080.97 |
| 8 | Tax expense | |||||
| - Current tax (Refer Note 5) | 1,482.45 | 2.433.47 | 732.28 | 5,100.13 | 2,169.43 | |
| - Deferred tax (Refer Note 5) | 19,90 | 0.78 | 499.71 | 125.00 | 806.24 | |
| - Tax in respect of earlier years | (3.29) | (3.29) | ||||
| 9 | Profit for the period (after tax) (7-8) | 4,478.73 | 7,785.01 | 2,010.15 | 16,120.25 | 7,108.59 |
| 10 | Other Comprehensive Income / (Loss) | |||||
| A (i) Items that will not be reclassified to profit or loss (Refer Note 4) | 366.72 | (1,662.38) | 734.44 | 18.129.28 | 9,435.83 | |
| (ii) Income tax relating to the items that will not be reclassified to profit or loss | (106.90) | 246.22 | (131.57) | (3,054.46) | (1, 479.33) | |
| B (i) Items that will be reclassified to profit or loss (ii) Income tax relating to the items that will be reclassified to profit or loss |
||||||
| 11 | Total Comprehensive Income / (Loss) for the period (9+10) | 4,738.55 | 6,368.85 | 2,613,02 | 31.195.07 | 15,065.09 |
| 12 | Paid up Equity Share Capital (face value of Rs. 5/- per Equity Share) | 628.53 | 628.53 | 628.53 | 628.53 | 628.53 |
| 13 | Earnings per share (EPS) - in Rs. | |||||
| Earning Per Shares of Rs 5/- each (not annualised) | ||||||
| Basic | 35.63 | 61.93 | 15,99 | 128.24 | 56.55 | |
| Diluted | 35.63 | 61.93 | 15.99 | 128.24 | 56.55 | |
STATEMENT OF CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2022
$M$
S IRI
MUMBA
400102

Chemicals Business | Environment & Biotech Division
Polymer Inputs | Pharmaceutical Intermediates | Veterinary API's
Excel Industries Limited
184-87, S. V. Road, Jogeshwari (West),
Mumbai - 400 102, Maharashtra, India.
CIN : L24200MH1960PLC011807
E : excelmumbai@excelind com
T : 91- 22 - 6646 4200
F : +91-22-2678 3657
W: www.excelind.co.in


NOTES TO CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR MARCH 31, 2022
- 1 The consolidated financial results for the quarter and year ended March 31, 2022 were reviewed by the Audit Committee and approved by the Board of Directors of Excel Industries Limited ('the Company') at their meetings held on May 27, 2022.
- 2 The Board of Directors have recommended dividend of $450^{\circ}/_{\circ}$ amounting to Rs. $22.5/-$ per equity share of Rs. 5.00 each (Previous vear : Rs. 11.25 per equity share) for the year ended March 31, 2022 subject to approval of shareholders.
- 3 The figures for the quarter ended March 31, 2022 and March 31, 2021 are arrived at as difference between audited figures in respect of the full financial year ended March 31, 2022 and March 31, 2021, and unaudited figures up to nine months ended December 31, 2021 and December 31, 2020 respectively, which were reviewed earlier and not subjected to audit.
- 4 Other Comprehensive Income include increase in Fair Value of Investments in equity instruments amounting to Rs, 404.11 lakhs and Rs, 18,128.63 lakhs for the quarter and year ended March 31, 2022.
- 5 During the previous year, current tax expenses for the quarter and year ended March 31, 2021 included Rs. 65.82 lakhs being the tax impact of goodwill taken out of purview of tax depreciation with effect from April 1, 2020 by Finance Bill enacted in March 2021. Further, deferred tax charge for the quarter and year ended March 31, 2021 included Rs. 282.33 lakhs being the deferred tax liabilities recognised by the Company on difference between book based and tax base of goodwill consequent upon enactment of above provision.
- 6 The Ministry of Corporate Affairs through a notification dated March 24, 2021, amended Schedule III of the Companies Act, 2013, applicable for financial periods commencing from April 1, 2021. Pursuant to such amendments, security deposits amounting to Rs. 711.87 lakhs as at March 31, 2021 have been reclassified from 'Loans' to 'Other financial assets' and current maturities of long term debts amounting to Rs. 1.57 lakhs as at March 31, 2021 have been reclassified from 'Other financial liabilities' to 'Current borrowings'. These reclassifications were also considered in the Statement of Consolidated Cash Flows for the vear ended March 31, 2021-
STR MUMBAI 400102

Excel Industries Limited 184-87, S. V. Road, Jogeshwari (West). Mumbai - 400 102. Maharashtra, India. CIN: L24200MH1960PLC011807
E: [email protected] $T: 91 - 22 - 66464200$ F: +91-22-2678 3657 W: www.excelind.co.in


7 Segment information:
| For the Quarter Ended | For the Year Ended | (Rs. In Lakhs) | |||
|---|---|---|---|---|---|
| March 31, 2022 | December 31.12021 | March 31, 2021 | March 31, 2022 | March 31, 2021 | |
| Particulars | (Unaudited) (Refer Note 3) |
(Unaudited) | (Unaudited) (Refer Note 3) |
(Audited) | (Audited) |
| Segment Revenue (Revenue from operations) | |||||
| Chemicals | 35,944.65 | 34.138.52 | 21.351.86 | 115,253,96 | 72.993.84 |
| Environment and Biotech | 521.89 | 913.87 | 515.95 | 2,548.02 | 1.952.76 |
| Total Segment Revenue | 36,466,54 | 35,052,39 | 21,867,81 | 117,801.98 | 74,946.60 |
| Less: Inter segment revenue | |||||
| Net Segment Revenue | 36,466.54 | 35,052.39 | 21,867.81 | 117,801.98 | 74,946.60 |
| Segment Results (Profit before tax and interest) |
|||||
| Chemicals | 7.456.28 | 10.818.46 | 4.267.80 | 24.827.19 | 13,080,08 |
| Environment and Biotech | (56, 38) | 212.39 | (35,08) | 256.88 | 8.25 |
| Total Segment Results | 7,399.90 | 11,030.85 | 4,232.72 | 25,084,07 | 13,088.33 |
| Less: Finance cost Other unallocable expenditure |
43.88 | 43.01 | 42.95 | 193.79 | 217.88 |
| (net of unallocable income) | 1.374.94 | 768.58 | 950.92 | 3,544.90 | 2,789.48 |
| Profit before tax | 5,981.08 | 10,219.26 | 3.238.85 | 21.345.38 | 10,080.97 |
| Segment Assets | |||||
| Chemicals | 78.735.62 | 72,380.38 | 61.441.26 | 78,735.62 | 61.441.26 |
| Environment and Biotech | 1.986.31 | 1,885.55 | 1,375.66 | 1,986.31 | 1,375.66 |
| Unallocated | 67,942.65 | 65,107.24 | 48,298.00 | 67,942.65 | 48.298.00 |
| Total Segment Assets | 148,664.58 | 139,373.17 | 111,114.92 | 148,664.58 | 111,114.92 |
| Segment Liabilities | |||||
| Chemicals | 18,556.07 | 14,431.17 | 12,824.58 | 18,556.07 | 12,824.58 |
| Environment and Biotech | 467.60 | 348.74 | 235.16 | 467.60 | 235.16 |
| Unallocated | 14,706.00 | 14,396.74 | 12,901.13 | 14,706.00 | 12,901.13 |
| Total Segment Liabilities | 33,729.67 | 29,176.65 | 25,960.87 | 33,729.67 | 25,960.87 |
Place: Mumbai Date: May 27, 2022

400102 m
JSTR
MUMBAI
For EXCET MOUSTRIES LIMITED
ASHWIN C. SHROFF
DIN: 00019952
EXECUTIVE CHAIRMAN
Chemicals Business | Environment & Biotech Division Polymer Inputs | Pharmaceutical Intermediates | Veterinary API's
Excel Industries Limited 184-87, S. V. Road, Jogeshwari (West),
Mumbai - 400 102, Maharashtra, India.
CIN : L24200MH1960PLC011807
E : [email protected]
T : 91- 22 - 6646 4200 F: +91-22-2678 3657 W: www.excelind.co.in


STATEMENT OF CONSOLIDATED ASSETS AND LIABILITIES
| (Rs. in Lakhs) As at |
||||
|---|---|---|---|---|
| Sr. No. | Particulars | March 31, 2022 (Audited) |
March 31, 2021 (Audited) |
|
| Α | Assets | |||
| 1 | Non-current assets | |||
| Property, plant and equipment | 38,463.73 | 34,593.80 | ||
| Right of use assets | 2,222.07 | 2,289.50 | ||
| Capital work in progress | 2,120.25 | 1,685.19 | ||
| Investment properties | 83.40 | 85.32 1,918.46 |
||
| Intangible assets Financial assets |
1,918.99 | |||
| (i) Investments in joint venture and associates | 0.10 | |||
| (ii) Other Investments (Refer Note 4) | 53,465.75 | 34,970.47 | ||
| (iii) Loans (Refer Note 6) | 4.37 | 5.14 | ||
| (iv) Other financial assets (Refer Note 6) | 630.49 | 621.65 | ||
| Current tax assets (net) | 1,788.66 | 1,807.65 | ||
| Other non-current assets | 119.15 | 218.32 | ||
| Total non-current assets | 100,816.96 | 78,195.50 | ||
| $\mathbf 2$ | Current assets | |||
| Inventories | 16,522.58 | 6,897.11 | ||
| Financial assets | ||||
| (i) Investments | 1,196.80 | 1,575.21 | ||
| (ii) Trade receivables | 19,920.77 | 17,263.91 | ||
| (iii) Cash and cash equivalents | 3,030.76 3,767.04 |
4,234.85 971.27 |
||
| (iv) Bank balances other than (iii) above (v) Loans (Refer Note 6) |
132.44 | 134.51 | ||
| (vi) Other financial assets (Refer Note 6) | 241.87 | 179.89 | ||
| Other Current assets | 3,035.36 | 1,662.67 | ||
| Total current assets | 47,847.62 | 32,919.42 | ||
| Total Assets | 148.664.58 | 111, 114.92 | ||
| B | Equity and Liabilities | |||
| 1 | Equity | |||
| Equity share capital | 628.53 | 628.53 | ||
| Other equity | 114,306.38 | 84,525.52 | ||
| Total equity | 114,934.91 | 85.154.05 | ||
| Liabilities | ||||
| $\overline{\mathbf{2}}$ | Non-current liabilities | |||
| Financial liabilities | ||||
| (i) Borrowings | 0.55 | |||
| (ii) Lease liabilities | 178,33 | 217.33 | ||
| Employee benefit obligations | 1,421.43 11,884.03 |
1,296.45 8.704.57 |
||
| Deferred tax liabilities (net) Total Non-current liabilities |
13,483.79 | 10,218.90 | ||
| 3 | Current liabilities | |||
| Financial liabilities | ||||
| (i) Borrowings (Refer Note 6) | 523.53 | 608.69 | ||
| (ii) Trade payable | ||||
| (a) total outstanding dues of micro and small enterprises | 1,432.38 | 1,160.87 | ||
| (b) total outstanding dues other than (ii) (a) above | 16,612.40 | 11,139.76 | ||
| (iii) Lease Liabilities | 39.18 | 33.73 | ||
| (iv) Other financial liabilities (Refer Note 6) | 456.62 | 1,550.53 | ||
| Employee benefit obligations Current tax liabilities (net) |
510.16 311.06 |
735.93 180.78 |
||
| Other current liabilities | 360.55 | 331.68 | ||
| Total current liabilities | 20,245.88 | 15,741.97 | ||
| Total Equity and Liabilities | 148.664.58 | 111,114.92 | ||
| 315 | ||||
| MUMBA 400102 Đ. |
$\overline{\text{M}$ 1mbat $\star$
冰
Excel Industries Limited
184-87, S. V. Road, Jogeshwari (West),
Mumbai - 400 102, Maharashtra, India.
CIN : L24200MH1960PLC011807
E : [email protected]
T : 91- 22 - 66464200
F : +91-22-2678 3657 W: www.excelind.co.in


IS/ISO 14001 :2015 IS 18001:2007 Certified by BIS.
STATEMENT OF CONSOLIDATED CASH FLOWS
| ear En e | ||
|---|---|---|
| Particulars | March 31, | March 31, |
| 2022 | 2021 | |
| Audited | Audited | |
| CASH FLOW FROM OPERATING ACTIVITIES: | ||
| Profit before tax | 21,345.38 | 10,080.97 |
| Adjustments for: | ||
| Depreciation and amortisation expenses | 3,065.50 | 2,715.32 |
| Finance costs | 193.79 | 217.88 |
| Provision for doubtful debts (net) | 26.08 | 154.64 |
| Provision for doubtful advance | 80.78 | 83.78 |
| Unrealised exchange differences (net) | 38,43 | 13.68 |
| Dividend income | (1,146.69) (256.65) |
(409.53) (165.91) |
| Interest income Gain on fair valuation of investments through profit and loss |
(13.00) | (66.93) |
| Net profit on disposal of property | (137.05) | |
| Profit on sale of investment | (42.62) | |
| Net loss on sale I discard of property, plant and equipment | 30,38 | 38.58 |
| Operating profit before working capital changes | 23,321.38 | 12,525.43 |
| Adjustments for: | ||
| (Increase) I decrease in Inventories | (9,625.47) | 874,86 |
| (Increase) I decrease in Trade Receivables | (2,669.79) | (2,455.74) |
| (Increase) I decrease in Other Bank balances | 685.01 | (821.19) |
| (Increase) I decrease in Loans (Current and Non current) (Refer Note 6) | 2.84 | (15.87) |
| (Increase) I decrease in Other Financial Assets (Current and Non current) (Refer Note 6) | (41.57) | (74.42) |
| (Increase) I decrease in Other Assets (Current and Non current) | (1,439.82) | (516.02) |
| Increase I (decrease) in Trade Payables | 5,692.57 | 1,802.88 |
| Increase I (decrease) in Other Financial Liabilities (Current and Non current) | (9.60) | 11.86 |
| Increase I (decrease) in Employee benefit obligations (Current and Non current) | (100.14) | (13.78) |
| Increase I (decrease) in Other Current Liabilities | 28.87 | 101.77 |
| 15,844.28 | 11,419.78 | |
| Less: Income taxes paid (net of refunds) NET CASH INFLOW GENERATED FROM OPERATING ACTIVITIES· [A) |
4,950.86 10 893.42 |
2,334.15 9,085.63 |
| CASH FLOW FROM INVESTING ACTIVITIES: | ||
| Purc�ase of Tangible assets (including capital work in progress, capital advances and Capital Vendor) | (7,370.71) | (4,769.46) |
| Purchase of Intangible assets | (18.73) | (2.04) |
| Payment towards acquisition | (1,000.00) | (750.00) |
| Proceed from sale of fixed assets | 20.20 | 16.24 |
| Proceed from sale of Investment property | 191.94 | |
| Proceeds from sale of Investments | 554.51 | 50.00 |
| Interest received | 227.40 | 166.16 |
| Investments in joint venture and associates | (0.10) | |
| Investments in bank deposits with maturity of more than three months (net) | (3,480.78) | |
| Dividend received | 1,146.69 | 409.53 |
| Purchase of current and non current investments | 487.06 | 572.15 |
| NET CASH INFLOW/ (OUTFLOW) FROM INVESTING ACTIVITIES· [B] | 10,408.58 | 5,259.78 |
| CASH FLOW FROM FINANCING ACTIVITIES: | ||
| Repayment of Borrowings | (85.71) | (1,523.16) |
| Principal elements of lease payments | (53.14) | (50.39) |
| Repayment of Fixed deposits accepted from public (including Interest) | (1.33) | (0.97) |
| Dividend Paid | (1,415.70) | |
| Interest Paid NET CASH (OUTFLOW) FROM FINANCING ACTIVITIES· [C] |
133.05 1,688.93 |
108.85 1,683.37 |
| NET INCREASE/ (DECREASE) IN CASH AND CASH EQUIVALENTS· [A+B+C] | 2,142.48 | |
| (1,204.09) | 2,092.37 | |
| 4,234.85 | 4,234.85 | |
| Add: Cash and cash equivalents at the beginning of the year ) S Rt� Cash and cash equivalents at the end of the year � |
3,030.76 |
Chemicals Business I Environment & Biotech Division Polymer Inputs I Pharmaceutical Intermediates I Veterinary APl's Excel Industries Limited 184-87, S. V. Road, Jogeshwari (West), Mumbai - 400 102, Maharashtra, India. CIN: L24200MH1960PLC011807
T: 91- 22 - 6646 4200
F: +91-22-2678 3657 W: www.excelind.co.in